baber/WOPTO huggingface dataset:
Patent AU-2019325593-A1 (AU)
Title: Treatment of triple negative breast cancer with targeted TGF-B inhibition
Inventor: LOCKE GEORGE
IPC: G01N33/574
Filed: 2019-08-22
Abstract: The present disclosure relates generally to methods for treating a patient diagnosed with triple negative breast cancer (TNBC), involving identifying a patient likely to respond to treatment via targeted TGF-β inhibition with an anti-TGFβ agent, and treating the subject with the anti-TGFβ agent.
Patent AU-2019344274-A1 (AU)
Title: Method for encoding/decoding image signal and apparatus therefor
Inventor: LEE BAE KEUN
IPC: H04N19/513
Filed: 2019-09-20
Abstract: An image decoding method according to the present invention comprises the steps of: generating a merge candidate list for a first block; selecting one from among merge candidates included in the merge candidate list; and performing motion compensation on the first block on the basis of motion information about the selected merge candidate, wherein inter region merge candidates included in an inter region motion information table can be added to the merge candidate list on the basis of the number of spatial merge candidates and temporal merge candidates included in the merge candidate list.
Patent AU-2019345061-A1 (AU)
Title: Systems and methods treating for corneal ectatic disorders
Inventor: RAJPAL RAJESH K
IPC: A61F9/007
Filed: 2019-09-19
Abstract: To treat corneal ectatic disorders, systems and methods can precisely apply photoactivating light to specified areas of a cornea treated with a cross-linking agent. An example system includes a light source that provides a photoactivating light to photoactivate a cross-linking agent applied to an eye. The system includes optical element(s) that transmit the photoactivating light to the eye according to a pattern defined by a plurality of treatment zones. The treatment zones are delivered to different respective areas on the eye. The plurality of treatment zones includes at least a first treatment zone and a second treatment zone. The first treatment zone provides a first dose of the photoactivating light. The second treatment zone provides a second dose of the photoactivating light. The first dose is greater than the second dose. The first treatment zone is disposed within an inner boundary of the second treatment zone.
Patent AU-2019352500-A1 (AU)
Title: Treatment delivery system
Inventor: KENDALL MARK ANTHONY FERNANCE
IPC: A61B5/145
Filed: 2019-10-01
Abstract: A system for delivering treatment to a biological subject, the system including: at least one substrate including a plurality of microstructures configured to breach a stratum corneum of the subject; at least one sensor operatively connected to at least one microstructure, the at least one sensor being configured to measure response signals from the at least one microstructure; at least one treatment delivery mechanism operatively coupled to at least one microstructure to deliver treatment via at least one microstructure; and, one or more electronic processing devices that are configured to control the at least one treatment delivery mechanism to thereby deliver treatment to the subject at least partially in accordance with the measured response signals.
Patent AU-2019390462-A1 (AU)
Title: Method and device for determining tower clearance for wind turbine
Inventor: WANG BAIFANG
IPC: F03D17/00
Filed: 2019-09-30
Abstract: A method and device for determining a tower clearance for a wind turbine. The method comprises: acquiring an image of a wind turbine in operation (S10), the image comprising the tips of blades (2) and a tower (1) of the wind turbine; determining the positions of the tips of the blades (2) of the wind turbine in the image acquired (S20); identifying the edges of the tower (1) in the image acquired (S30); and calculating, on the basis of the positions of the tips of the blades (2) and the edges of the tower (1) that have been determined, the distance from the tips (2) of the blades (2) to the edges of the tower (1) to acquire a tower clearance (S40). The employment of the method and device for determining the tower clearance for the wind turbine allows the real-time determination of the tower clearance for the wind turbine, thus effectively preventing the blades (2) from hitting the tower.
Patent AU-2019394038-A1 (AU)
Title: Skincare and antibacterial microcapsule finishing agent, and preparation method therefor and application thereof
Inventor: CAO ZIYI
IPC: D06M13/03
Filed: 2019-05-09
Abstract: Disclosed are a skincare and antibacterial microcapsule finishing agent, and a preparation method therefor and application thereof. The finishing agent comprises an organosilicon microcapsule; the surface of the organosilicon microcapsule is modified by using an organosilicon quaternary ammonium salt; in the organosilicon microcapsule, an aloe extraction liquid and squalene are used as core materials, and tetraethylorthosilicate wall material. A non-adhesive skincare and antibacterial microcapsule finishing agent is obtained by first preparing the organosilicon microcapsule by means of a sol-gel method, and then using the organosilicon quaternary ammonium salt to modify the prepared microcapsule. When in use, the finishing agent is directly added into a cellulose fiber fabric post-finishing liquid, without adding an adhesive; a finished fabric has lasting skincare and moisturizing effects, and also has lasting antibacterial performance; moreover, the touch feel and style of the fabric are not affected.
Patent AU-2019395706-A1 (AU)
Title: Water based dispersion to make coatings with increased MVTR barrier properties out of it
Inventor: DE ZEEUW ARD
IPC: C09D165/00
Filed: 2019-12-02
Abstract: The present invention relates to an aqueous dispersion, comprising or consisting of A) at least one cyclic olefin copolymer, B) at least one surfactant; optionally C) at least one adhesion promoter; optionally D) at least one film-forming resin; optionally E) at least one additive; and F) water. Additionally, the invention relates to methods of manufacturing the aqueous dispersion, to an article, which comprises at least one substrate and at least one coating layer obtained from the aqueous dispersion and applied onto the substrate; and to the use of the aqueous dispersion for coating a substrate.
Patent AU-2019398111-A1 (AU)
Title: Nrf-2 deficient cells and uses thereof
Inventor: HONG CHANG WAN
IPC: C12N5/16
Filed: 2019-12-09
Abstract: The present disclosure relates to T cell anticancer immunotherapy based on modulation of Nrf2 expression, that is, to an Nrf2-targeting immune cell, e.g., T cell, anticancer therapy. The present disclosure allows deep interference with the Nrf2 expression in T cells, thereby solving the problem of immune tolerance shown by cancer cells to T cells; in other words, the effect of anticancer immunotherapy can be improved by targeting Nrf2. The present disclosure can provide an Nrf2-targeting new T cell anticancer immunotherapy and a T cell for the second-generation anticancer immunotherapy. This technology is applicable to the preparation of CAR-T, engineered T, and TIL T cells, and to the treatment of various solid carcinomas, including lymphoma. It can be said to be a new anticancer therapy that improves the therapeutic efficacy effectively.
Patent AU-2019406845-A1 (AU)
Title: Radar for tracking or generating radar images of passive objects
Inventor: TROUTMAN DENNIS
IPC: G01S13/02
Filed: 2019-09-20
Abstract: An ultra wide band (UWB) based radar system and method uses reflected UWB signal pulses to locate and/or track objects having a detectable radar cross-section. The system and method use the same types of UWB transceivers used to track active RF tags and includes a method of processing channel impulse response data allowing the detection, location, and tracking of non-tagged objects within a monitored area.
Patent AU-2019411887-A1 (AU)
Title: Weed control method
Inventor: SADA YOSHINAO
IPC: A01N57/20
Filed: 2019-12-20
Abstract: The present invention relates to a dicamba-resistant weed control method including a step in which dicamba or a salt thereof and one or more different herbicides are applied to a dicamba-resistant weed or the habitat of a dicamba-resistant weed. The present invention allows the provision of a method that demonstrates a superior control effect for weed control.
Patent AU-2019418308-A1 (AU)
Title: Method and apparatus for dispensing a beverage in chilled condition
Inventor: ZANETTE ALEX
IPC: B67D1/08
Filed: 2019-12-23
Abstract: A mobile beverage dispenser comprises a wheelable platform having mounted thereon a chillable chamber connected to a refrigerated cooling coil for removing heat from a beverage in a bulk storage container placed therein for cooling; and a beverage dispensing tap connectable to the container in fluid communication with the beverage, and mounted in thermally conductive relationship with the chillable chamber, whereby the chamber when chilled removes heat from the dispenser in preparation for dispensing of the beverage, by virtue of the conductive relationship.
Patent AU-2020200315-A1 (AU)
Title: Use of cart19 to deplete normal b cells to induce tolerance
Inventor: LEVINE BRUCE L
IPC: A61K48/00
Filed: 2020-01-16
Abstract: The present invention provides compositions and methods for inducing tolerance in a human. The invention includes administering a genetically modified T cell expressing a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signalling region, and a CD3 zeta signalling domain. WO 2014/012001 PCT/US2013/050293 V4p zS </
Patent AU-2020204342-A1 (AU)
Title: A liquid formulation comprising nicotine for aerosol administration
Inventor: MUHAMMED SALIH MUSHIN
IPC: A24F40/40
Filed: 2020-06-29
Abstract: In one aspect, the present invention features a method of administering nicotine or a 
salt thereof to a human, wherein the method includes inhaling an aerosol of a liquid 
formulation, the liquid formulation comprising: (i) at least 12 percent by weight of water; (ii) 
5 at least 70 percent by weight of propylene glycol; and (iii) at least 2 percent by weight of said 
nicotine or a salt thereof; wherein the liquid formulation includes no more than 5 percent by 
weight of glycerol and no more than 5 percent by weight of ethanol. The present invention 
also features an aerosol-generating device and a reservoir for such a device containing such a 
liquid formulation.
Patent AU-2020210302-A1 (AU)
Title: Audio system with sound-field-type nature sound effect
Inventor: CHEN HSI-HSIEN
IPC: H01S1/00
Filed: 2020-07-31
Abstract: OF THE DISCLOSURE 
An audio system with sound-field-type nature sound effect includes: a first primary 
channel playing device for playing a primary audio signal generated according to a left 
channel audio signal and/or a right channel audio signal; a first secondary signal circuit for 
generating a first secondary audio signal according to the left channel audio signal and the 
right channel audio signal; and a first sound field control playing device connected to the first 
secondary signal circuit and adapted to play the first secondary audio signal; wherein a first 
playing delay period exists between the playing of the first secondary audio signal and the 
playing of the primary audio signal; wherein the first secondary audio signal played by the 
first sound field control playing device does not undergo audio mixing with the primary audio 
signal by a first audio mixing circuit.  
13416408_1 (GHMatters) P114110.AU
1/11 
100 
110 
120 
First primary channel playing 
device 
Primary channel 
front-end circuit / 130 
__Second primary channel 
playing device 
140- - 150 
First secondary First sound field control 
signal circuit playing device 
160 170 
Second secondary Second sound field control 
signal circuit playing device 
FIG.1
Patent AU-2020217910-A1 (AU)
Title: Radar location system and method
Inventor: MENIS BOAZ
IPC: G01S7/41
Filed: 2020-02-04
Abstract: Methods of defining a virtual fence and for detecting a body inside or outside a region of interest defined by the virtual fence and/or of determining a height for a body on a surface in a region of interest use radar signals and a configuration mode and a monitoring mode are disclosed. In the configuration mode coordinates for defining a virtual fence are determined and/or a topology of a surface in the region of interest is determined. In the monitoring mode, a location of a second body on the surface is detected to determine if the second body is inside or outside the virtual fence and/or a height of for the second body relative to the determined topology is determined.
Patent AU-2020224678-A1 (AU)
Title: Solid polymorphs of a FLNA-binding compound and its hydrochloride salts
Inventor: ZAMLOOT MICHAEL
IPC: C07D471/10
Filed: 2020-02-21
Abstract: The preparation and properties of crystalline polymorphs and solvates of 1-benzyl-8-methyl-1,4,8-triazaspiro-[4.5]-decan-2-one free base and of the mono-and dihydrochloride salts and solvates thereof are disclosed, as is an amorphous polymorph of the dihydrochloride. A pharmaceutical composition containing one or more polymorphs and a method of using that composition are also disclosed.
Patent AU-2020227077-A1 (AU)
Title: Beta-lactamase inhibitors and uses thereof
Inventor: GORDON ERIC M
IPC: A61P31/04
Filed: 2020-09-03
Abstract: p-Lactamase inhibiting compounds, therapeutic methods of using the p-lactamase inhibiting 
compounds, particularly in combination with p-lactam antibiotics and pharmaceutical compositions 
thereof are disclosed. The p-lactamase inhibiting compounds are suitable for oral administration.
Patent AU-2020229800-A1 (AU)
Title: Medication delivery device with sensing system
Inventor: FRIEDLANDER JAY MARK
IPC: A61M5/315
Filed: 2020-02-20
Abstract: Medication delivery devices are provided having a housing comprising a reservoir sized sufficiently to hold medication, a dose button being rotatable relative to the housing to select a dose size of the medication for an injection, a printed circuit board, a switch mounted to the printed circuit board, and a controller in communication with the switch. The controller is configured to generate a first count of a set of signals using a first counting technique, generate a second count of the set of signals using a second counting technique, and determine, based on the first and second count, reliability data of the first and/or second count. The controller can connect, using a wireless communication module, to a remote computing device to wirelessly communicate with the remote computing device over an unencrypted wireless communication channel, and transmit, using the wireless communication module, encrypted data to the remote computing device.
Patent AU-2020268982-A1 (AU)
Title: Restoration of the CFTR function by splicing modulation
Inventor: KEREM BAT SHEVA
IPC: C12N15/113
Filed: 2020-05-05
Abstract: The present invention provides oligonucleotides capable of binding to and modulating the splicing of the pre-mRNA of the CFTR gene, including compositions comprising the oligonucleotides, and uses thereof, such as for suppressing the inclusion of a cryptic exon between exon 22 and 23 as a result of the mutation 3849 +10Kb C-to-T, optionally in combination with additional CF therapeutics.
Patent AU-2020273354-A1 (AU)
Title: Skin cancer treatment
Inventor: MOTTA ALEXANDRE CHARLES ROGER
IPC: A61K31/475
Filed: 2020-11-20
Abstract: The present invention relates to the fields of medicine and cancer, more particularly to the 
field of skin cancer (e.g. melanoma and non-melanoma cancers) and skin cancer 
treatment. Provided are methods for treating skin cancer using microneedle devices for 
the removal of an amount of interstitial fluid or tumor interstitial fluid from a skin tumor.  
Also provided are therapeutic compounds for use in the treatment of skin cancer, wherein 
the treatment comprises removal of an amount of interstitial fluid or tumor interstitial fluid 
from a skin tumor.
3/5 
Fig. 3 
Site of needles insertion 
Tumoroid 1 Tumoroid 3 
-- CO-
Tumoroid 2 
Tumoroid 4 
=direction of the flow of tumoroid-derived soluble factors 
induced by the action of the needle device inside the gel as 
they are being extracted.
Patent AU-2020277231-A1 (AU)
Title: 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Inventor: BECKWITH ROHAN ERIC JOHN
IPC: C07D401/04
Filed: 2020-11-26
Abstract: The present disclosure provides a compound of Formula (I'): 
0 0 
NH 
(RX)q N 3 0 
R2 n (I'), 
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer 
thereof, wherein R 1, R2 , R, X1, n, nl, and q are as defined herein, and methods of making and use 
5 for the treatment of IKAROS Family Zinc Finger 2 (IKZF2)-dependent diseases or disorders or 
where reduction of IKZF2 or IKZF4 protein levels can ameliorate a disease or disorder.
Patent AU-2020286909-A1 (AU)
Title: A bearing with pads having cooling micro-channels therein, and method
Inventor: RAVEGGI MARCO
IPC: F16C17/03
Filed: 2020-06-03
Abstract: The bearing has a housing and a plurality of pads coupled with the housing. The pads form bearing surfaces facing a shaft receiving space. The pads are provided with cooling micro-channels formed therein, adapted to circulate lubrication fluid and improve heat removal.
Patent AU-2020291114-A1 (AU)
Title: Heteroaromatic inhibitors of astacin proteinases
Inventor: RAMSBECK DANIEL
IPC: A61K31/437
Filed: 2020-06-12
Abstract: The present invention relates to novel hydroxamic acid derivatives useful as inhibitors of astacin metalloproteinases, in particular procollagen C-proteinase (PCP) enzymes, meprins, ovastacin and/or nematode astacins; more particularly human or mammalian meprin α, meprin β, BMP-1, ovastacin and/or DPY-31 from nematodes; pharmaceutical compositions comprising such compounds; methods for treatment or prophylaxis of diseases or conditions, especially such that are related to said metalloproteinases; and compounds and pharmaceutical compositions for use in such methods.
Patent AU-2020293021-A1 (AU)
Title: PRMT5 inhibitors
Inventor: GUDADE GANESH BHAUSAHEB
IPC: A61K31/519
Filed: 2020-06-09
Abstract: The invention relates to substituted nucleoside analogues of formula (I), pharmaceutically acceptable salts thereof and pharmaceutical compositions for treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme. The invention also relates to methods of treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme.
Patent AU-2020314880-A1 (AU)
Title: System and method for producing un-hydrogenated and hydrogenated C9+ compounds
Inventor: KHURRAM SHEHZADA
IPC: C10G9/36
Filed: 2020-07-13
Abstract: A system and method for processing pyrolysis gasoline is disclosed. The system and method involves separating a pyrolysis gasoline stream to produce a first stream comprising primarily un-hydrogenated C
Patent AU-2020317357-A1 (AU)
Title: Walk-behind self-propelled working machine
Inventor: REN YUFEI
IPC: A01D34/68
Filed: 2020-07-24
Abstract: Provided is a back-traveling self-propelled work machine, comprising: a main machine (12), comprising a travel assembly (121) and a drive motor (122) for driving the travel assembly (121); an operation switch (112c), connected to the drive motor (122); a handle apparatus (11), connected to the main machine (12); the handle apparatus comprises: an operation member (112), comprising a grip part for a user to grip; a connecting rod (111), connected to the main machine (12); a sensing module (14), used for sensing the pushing force applied to the handle apparatus (11) to drive the back-traveling self-propelled work machine; the sensing module (14) also comprises: a pressure sensor (141a), arranged between the operation member (112) and the connecting rod (111); a pressing member (146); when the grip part is subjected to a pushing force, the pressing member (146) applies a force along a preset linear direction to the pressure sensor (141a) so as to drive the pressure sensor (141a) to deform.
Patent AU-2020323969-A1 (AU)
Title: Method for making hydrogen storage alloys
Inventor: AGUEY-ZINSOU KONDO-FRANCOIS
IPC: C21D9/00
Filed: 2020-08-05
Abstract: The present disclosure relates to methods for preparing TiMn-based or TiCrMn-based hydrogen storage alloys capable of absorbing and releasing hydrogen. In preferred embodiments the TiMn-based or TiCrMn-based hydrogen storage alloys comprise ferrovanadium (VFe).
Patent AU-2020332559-A1 (AU)
Title: Automated fluid system
Inventor: HAUGHS JAMES
IPC: E21B21/06
Filed: 2020-08-18
Abstract: A method of controlling the composition of a drilling fluid comprises receiving measurements of properties of a drilling fluid; determining a concentration of the components of the drilling fluid by inputting the measured properties to a fluid model that relates the properties of the drilling fluid to the concentrations of each of the components; determining a desired concentration of each of the plurality of components of the drilling fluid, by inputting desired properties of the drilling fluid to the fluid model; and determining a quantity of one or more additives to be added to the drilling fluid to achieve the desired concentration of each of the plurality of components. The invention includes a controller (20) for controlling the method and a system (1) therefor.
Patent AU-2020414932-A1 (AU)
Title: Claudin18.2 binding moieties and uses thereof
Inventor: FAN XIAOHU
IPC: C07K16/28
Filed: 2020-12-24
Abstract: Single domain antibodies that bind to Claudin18.2, and chimeric antigen receptors comprising same are provided. Further provided are engineered immune effector cells (such as T cells) comprising the chimeric antigen receptors. Pharmaceutical compositions, kits and methods of treating a disease or disorder are also provided.
Patent AU-2020418554-A1 (AU)
Title: Pharmaceutical composition for the prevention or treatment of post-surgical pain
Inventor: AZOULAI RENÉ
IPC: A61P29/00
Filed: 2020-12-31
Abstract: The invention relates to an anti-IL-6 agent for use in a method of preventing or treating post-surgical pain in a subject.
Patent AU-2020438610-A1 (AU)
Title: Soft through-air dried facial tissue
Inventor: SATORI CHRISTOPHER L
IPC: D21H27/40
Filed: 2020-03-27
Abstract: Disclosed are multi-ply tissue products, particularly creped and through-air dried facial tissue products, having improved strength and softness. For example, the products have a geometric mean tensile strength (GMT) greater than about 1,2000 g/3", a geometric mean tensile energy absorption (GM TEA) of about 20 g·cm/cm
Patent WO-2021248175-A1 (WO)
Inventor: HUETT ANDREW
IPC: B60D1/30
Filed: 2021-06-10
Abstract: A hitching system for connecting a towed vehicle to a towing vehicle comprising: a connector member for engaging with a connection point on the towing vehicle; a shaft member connected at one end to the connector member and at a second opposing end to a housing fixed to the towed vehicle; a plurality of sensor elements mounted to said shaft member, at least one of the sensor elements configured to measure a lateral force present in the shaft member during towing of the towed vehicle by the towing vehicle; and a computer processor mounted with respect to the towed vehicle for receiving a signal from at least one of the sensor elements representative of the measure of the lateral force present in the shaft member and processing said signal to control motion of the towed vehicle.